Essex Woodlands Healthcare Partners
110
37M
73
2.82
34
0.34
46
- Stages of investment
- Areas of investment
Summary
In 1985 was created Essex Woodlands Healthcare Partners, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Palo Alto.
Among the most popular fund investment industries, there are Biopharma, Hospital. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Inhibitex, Catalyst Biosciences, ikaSystems. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Essex Woodlands Healthcare Partners, startups are often financed by SV Health Investors, Johnson & Johnson Development Corporation, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, Novo Holdings, MPM Capital. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Novo Holdings, MPM Capital.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. Opposing the other organizations, this Essex Woodlands Healthcare Partners works on 6 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Essex Woodlands Healthcare Partners is 10-50 millions dollars. The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies.
The fund was created by Jim Currie, Marty Sutter. We also calculated 6 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 110
- Lead investments
- 34
- Exits
- 46
- Rounds per year
- 2.82
- Follow on index
- 0.34
- Investments by industry
- Health Care (76)
- Biotechnology (72)
- Medical (44)
- Medical Device (41)
- Pharmaceutical (31) Show 30 more
- Investments by region
-
- United States (90)
- France (1)
- Denmark (5)
- United Kingdom (5)
- Switzerland (1) Show 3 more
- Peak activity year
- 2007
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 116M
- Group Appearance index
- 0.71
- Avg. company exit year
- 17
- Avg. multiplicator
- 0.75
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kona Medical | 04 Dec 2012 | Health Care, Medical, Therapeutics | Late Stage Venture | 10M | United States, Washington, Bellevue |
| United Orthopedic Group | 01 Jan 2007 | Manufacturing, Medical Device, Medical | Seed | United States, California, Carlsbad | |
| Wizebank | 01 Dec 2020 | Internet, Software, FinTech | Seed | Vancouver, Alberta, Canada |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.